Endpoint definition
↥Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
List of similar endpoints to Carcinoma in situ, thyroid and other endocrine glands based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
All | Female | Male | |
---|---|---|---|
Number of individuals | 7 | - | - |
Unadjusted prevalence (%) | 0.00 | - | - |
Mean age at first event (years) | 51.21 | - | - |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | - | - | - | - |
15 years | - | - | - | - |
5 years | - | - | - | - |
1 year | - | - | - | - |
Index endpoint: CD2_INSITU_THYROICD2_ENDOCRINE – Carcinoma in situ, thyroid and other endocrine glands
GWS hits:
before Carcinoma in situ, thyroid and other endocrine glands
after Carcinoma in situ, thyroid and other endocrine glands
Loading survival analyses plot
Loading survival analyses table